US 12,064,331

Application 17/366,727 · Granted Aug 20, 2024

Implant loading device and system

Estimated expiration

November 18, 2025

Expired 368 days ago

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Nov 18, 2005
+ 20 years
Nov 18, 2025
PTA +475d
Mar 8, 2027
TD cap (US 10,350,048)
Nov 18, 2025
Final
Nov 18, 2025

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
July 2, 2021
Earliest effective filing
November 18, 2005
Issue date
August 20, 2024
PTA
+475 days
Base expiry (before PTA)
November 18, 2025

November 18, 2005 + 20 years = November 18, 2025 + 475 PTA days = March 8, 2027

  • Continuation of application 16/436,711, filed Jun 10, 2019, issued as US 11,083,556
  • Continuation of application 15/841,898, filed Dec 14, 2017, issued as US 10,350,048
  • Continuation of application 14/938,216, filed Nov 11, 2015, issued as US 9,872,755
  • Continuation of application 13/625,615, filed Sep 24, 2012, issued as US 9,211,181
  • Continuation-in-part of application 12/820,393, filed Jun 22, 2010, issued as US 8,388,682
  • Continuation of application 11/282,940, filed Nov 18, 2005, issued as US 7,771,472
  • Continuation-in-part of application 12/820,393, filed Jun 22, 2010, issued as US 8,388,682
  • Continuation of application 13/625,615, filed Sep 24, 2012, issued as US 9,211,181
  • Continuation of application 14/938,216, filed Nov 11, 2015, issued as US 9,872,755
  • Continuation of application 13/625,615, filed Sep 24, 2012, issued as US 9,211,181
  • Continuation-in-part of application 12/820,393, filed Jun 22, 2010, issued as US 8,388,682
  • Continuation of application 11/282,940, filed Nov 18, 2005, issued as US 7,771,472
  • Continuation of application 15/841,898, filed Dec 14, 2017, issued as US 10,350,048
  • Continuation of application 14/938,216, filed Nov 11, 2015, issued as US 9,872,755
  • Continuation of application 13/625,615, filed Sep 24, 2012, issued as US 9,211,181
  • PRO61/538,723 — Provisional — not used for base term
  • PRO60/630,399 — Provisional — not used for base term
  • PRO60/630,399 — Provisional — not used for base term
  • PRO61/538,723 — Provisional — not used for base term
  • PRO61/538,723 — Provisional — not used for base term
  • PRO61/538,723 — Provisional — not used for base term
  • PRO60/630,399 — Provisional — not used for base term
  • PRO61/538,723 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to November 18, 2025 (earliest expiring referenced patent: US 10,350,048)

  • US 10,350,048· Application 15/841,898Capping patent

    Implant loading device and system

    Filing date
    Dec 14, 2017
    Earliest effective filing
    Nov 18, 2005
    Issue date
    Jul 16, 2019
    PTA
    0 days
    Calculated expiration
    Nov 18, 2025

    Continuation of 14/938,216, filed Nov 11, 2015, issued as US 9,872,755

    Continuation of 13/625,615, filed Sep 24, 2012, issued as US 9,211,181

    Continuation-in-part of 12/820,393, filed Jun 22, 2010, issued as US 8,388,682

    Continuation of 11/282,940, filed Nov 18, 2005, issued as US 7,771,472

    Continuation-in-part of 12/820,393, filed Jun 22, 2010, issued as US 8,388,682

    Continuation of 13/625,615, filed Sep 24, 2012, issued as US 9,211,181

    Nov 18, 2005 + 20y = Nov 18, 2025

  • US 12,064,331· Application 17/366,727(from application 17/366,727)

    Implant loading device and system

    Filing date
    Jul 2, 2021
    Earliest effective filing
    Nov 18, 2005
    Issue date
    Aug 20, 2024
    PTA
    +475 days
    Calculated expiration
    Mar 8, 2027

    Continuation of 16/436,711, filed Jun 10, 2019, issued as US 11,083,556

    Continuation of 15/841,898, filed Dec 14, 2017, issued as US 10,350,048

    Continuation of 14/938,216, filed Nov 11, 2015, issued as US 9,872,755

    Continuation of 13/625,615, filed Sep 24, 2012, issued as US 9,211,181

    Continuation-in-part of 12/820,393, filed Jun 22, 2010, issued as US 8,388,682

    Continuation of 11/282,940, filed Nov 18, 2005, issued as US 7,771,472

    Continuation-in-part of 12/820,393, filed Jun 22, 2010, issued as US 8,388,682

    Continuation of 13/625,615, filed Sep 24, 2012, issued as US 9,211,181

    Continuation of 14/938,216, filed Nov 11, 2015, issued as US 9,872,755

    Continuation of 13/625,615, filed Sep 24, 2012, issued as US 9,211,181

    Continuation-in-part of 12/820,393, filed Jun 22, 2010, issued as US 8,388,682

    Continuation of 11/282,940, filed Nov 18, 2005, issued as US 7,771,472

    Continuation of 15/841,898, filed Dec 14, 2017, issued as US 10,350,048

    Continuation of 14/938,216, filed Nov 11, 2015, issued as US 9,872,755

    Continuation of 13/625,615, filed Sep 24, 2012, issued as US 9,211,181

    Nov 18, 2005 + 20y + 475d PTA = Mar 8, 2027

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/366,727 · US 12,064,331

PatentReply compiles the prosecution history behind US 12,064,331: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12064331

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.